From The Hindu BusinessLine
Center-Right Owned by The Hindu Group (Kasturi & Sons)India proposes immediate suspension of drug manufacturing licences over quality failures
What's behind this
The government has put forward a proposal to immediately suspend the manufacturing licences of drugs that are deemed not of standard quality on certain critical quality parameters. Under the proposed amendment, a suspension would remain in effect until the manufacturer implements mandatory corrective measures, after which the licence could be revoked. The move is described as a major step to strengthen the regulatory framework and ensure the quality and safety of medicines in the country.
AI-generated overview from 2 outlets. It summarises their reporting and adds no reporting of its own.
What each side is saying
One outlet's own words from each side of the spectrum. Quoted, not summarised.
-
left · 1 outlet
Proposed amendment provides for mandatory corrective measures before revocation of the suspension; suspension shall continue until the manufacturer undertakes corrective action
-
center · 3 outlets
New Delhi: The Union health ministry Wednesday said it has proposed immediate suspension of manufacturing licences for drugs found not of standard quality (NSQ) on critical parameters such as assay, dissolution and sterility, to ensure faster regulatory action against substandard medicines. The…
-
right · 1 outlet
The proposed changes seek to prevent substandard medicines from remaining in circulation while manufacturers address quality failures and regulatory concerns
RSS excerpt
The proposed changes seek to prevent substandard medicines from remaining in circulation while manufacturers address quality failures and regulatory concerns
